Gillmann Kevin, Bravetti Giorgio E, Mansouri Kaweh
Department of Ophthalmology, Glaucoma Research Center, Montchoisi Clinic, Swiss Visio, Lausanne, Switzerland.
J Curr Glaucoma Pract. 2019 Sep-Dec;13(3):113-115. doi: 10.5005/jp-journals-10078-1258.
The aim of this report is to explore the risk factors of XEN stent obstruction, suggesting the need for a stricter control of these factors and highlighting areas for further research.
Despite its proven effectiveness and safety profile, XEN gel stents (Allergan Plc, Dublin, Ireland) can become obstructed. The causes and predicting factors for such obstructions still require further research. While hyphema has long been known to be responsible for secondary glaucoma through trabecular obstruction, it has not been associated, to date, with XEN gel stent obstruction.
We describe the case of a 55-year-old female patient with primary open-angle glaucoma (POAG) who underwent bilateral XEN gel surgery. Her left eye developed a 2 mm postoperative hyphema, which resolved spontaneously within 8 days. Intraocular pressure (IOP) normalized at 12 mm Hg and increased to 50 mm Hg after 1 month in an otherwise normal-looking eye. Intraoperative examination revealed a nonfunctioning XEN gel stent, which was replaced and sent for laboratory analysis. Macroscopic examination of the tube confirmed obstruction with cellular debris. Tube replacement restored good filtration.
This case report confirms cellular debris as a potential cause of XEN gel stent occlusion, suggesting that aqueous red blood cells (RBCs) could potentially pose a threat to the microstents' patency even in cases when the bleeding was minimal and self-limited and where the IOP was still controlled at the time of full hyphema resolution. This observation could lead to recommendations for a stricter control of bleeding risk factors prior to microinvasive glaucoma surgery (MIGS), and it raises the question of whether anterior chamber (AC) washout should be advised in postoperative hyphema.
This case highlights some previously unreported risk factors for XEN stent obstruction and suggests that stricter control of bleeding and monitoring of patients following hyphema could improve surgical outcome.
Gillmann K, Bravetti GE, Mansouri K. Delayed Obstruction of XEN Gel Stent by Cell Debris in Primary Open-angle Glaucoma: A New Insight into the Pathophysiology of Filtration Device Failure. J Curr Glaucoma Pract 2019;13(3):113-115.
本报告旨在探讨XEN支架阻塞的危险因素,表明需要对这些因素进行更严格的控制,并突出进一步研究的领域。
尽管XEN凝胶支架(爱尔兰都柏林艾尔建公司)已被证明具有有效性和安全性,但仍可能发生阻塞。此类阻塞的原因和预测因素仍需进一步研究。虽然长期以来已知前房积血可通过小梁阻塞导致继发性青光眼,但迄今为止,它与XEN凝胶支架阻塞并无关联。
我们描述了一名55岁原发性开角型青光眼(POAG)女性患者接受双侧XEN凝胶手术的病例。她的左眼术后出现2mm前房积血,8天内自行吸收。眼压在12mmHg时恢复正常,1个月后在外观正常的眼睛中升至50mmHg。术中检查发现XEN凝胶支架无功能,予以更换并送去实验室分析。对导管的宏观检查证实有细胞碎片阻塞。更换导管后恢复了良好的滤过功能。
本病例报告证实细胞碎片是XEN凝胶支架阻塞的潜在原因,表明即使在出血极少且为自限性、前房积血完全吸收时眼压仍得到控制的情况下,房水中的红细胞(RBCs)仍可能对微支架的通畅性构成威胁。这一观察结果可能会促使人们建议在微创青光眼手术(MIGS)前更严格地控制出血危险因素,同时也引发了术后前房积血时是否应建议进行前房冲洗的问题。
本病例突出了一些以前未报道的XEN支架阻塞危险因素,并表明更严格地控制出血和在前房积血后对患者进行监测可能会改善手术效果。
吉尔曼K,布拉韦蒂GE,曼苏里K。原发性开角型青光眼中细胞碎片导致XEN凝胶支架延迟阻塞:对滤过装置失败病理生理学的新认识。《当代青光眼实践杂志》2019;13(3):113 - 115。